Rapid Detection of Point Mutations in the gyrA Gene of Helicobacter pylori Conferring Resistance to Ciprofloxacin by a Fluorescence Resonance Energy Transfer-Based Real-Time PCR Approach

Journal of Clinical Microbiology

Volumn 42, Issue 5, 2004, Pages 2241-2246

  Glocker, Erik ^a   Kist, Manfred ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; QUINOLONE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL GENE; CONTROLLED STUDY; ENERGY TRANSFER; FLUORESCENCE; GYRA GENE; HELICOBACTER PYLORI; NONHUMAN; NUCLEOTIDE SEQUENCE; PATIENT SELECTION; POINT MUTATION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

ANTI-INFECTIVE AGENTS; BACTERIOLOGICAL TECHNIQUES; BASE SEQUENCE; CIPROFLOXACIN; DNA GYRASE; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENES, BACTERIAL; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; POINT MUTATION; POLYMERASE CHAIN REACTION;

BACTERIA (MICROORGANISMS); HELICOBACTER; HELICOBACTER PYLORI;

EID: 2442451551     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.42.5.2241-2246.2004     Document Type: Article

References (14)

1. Cammarota, G., R. Cianci, O. Cannizzaro, L. Cuoco, G. Pirozzi, A. Gasbarrini, A. Armuzzi, M. A. Zocco, L. Santarelli, F. Arancio, and G. Gasbarrini. 2000. Efficacy of two one-week rabeprazol/levofloxacin-based triple therapies for Helicobacter pylori infection. Aliment. Pharmacol. Ther. 14:1339-1343.
2. Di Caro, S., M. Assunta Zocco, F. Cremonini, M. Candelli, E. C. Nista, F. Bartoluzzi, A. Armuzzi, G. Cammarota, I. Santarelli, and A. Gasbarrini. 2002. Levofloxacin based regimens for the eradication of Helicobacter pylori. Eur. J. Gastroenterol. Hepatol. 14:1309-1312.
3. Glupczynski, Y., F. Mégraud, M. Lopez-Brea, and L. P. Andersen. 2001. European multicentre survey of in vitro antimicrobial resistance in Helicobacterpylori. Eur. J. Clin. Microbiol. Infect. Dis. 20:820-823.
4. Heep, M., M. Kist, S. Strobel, D. Beck, and N. Lehn. 2000. Secondary resistance among 554 isolates of Helicobacter pylori after failure of therapy. Eur. J. Clin. Microbiol. Infect. Dis. 19:538-541.
5. Malfertheiner, P., F. Mégraud, C. O'Morain, A. P. S. Hungin, R. Jones, A. Axon, D. Y. Graham, G. Tytgat, and The European Helicobacter Pylori Study Group (EHPSG). 2002. Current concepts in the management of Helicobacter pylori infection - the Maastricht 2-2000 Consensus Report. Aliment. Pharmacol. Ther. 16:167-189.
6. Mégraud, F. 1998. Epidemiology and mechanism of antibiotic resistance in Helicobacter pylori. Gastroenterology 115:1278-1282.
7. Moore, R. A., B. Beckthold, S. Wong, A. Kureishi, and L. E. Bryan. 1995. Nucleotide sequence of the gyrA gene and characterization of ciprofloxacin-resistant mutants of Helicobacter pylori. Antimicrob. Agents Chemother. 39:107-111.
8. Reece, R. J., and A. Maxwell. 1991. DNA gyrase: structure and function. Crit. Rev. Biochem. Mol. Biol. 26:335-375.
9. Suerbaum, S. 2000. Genetic variability in Helicobacter pylori infection. Int. J. Med. Microbiol. 290:175-181.
10. Wang, G., T. J. Wilson, Q. Jiang, and D. E. Taylor. 2001. Spontaneous mutations that confer antibiotic resistance in Helicobacterpylori Antimicrob. Agents Chemother. 45:727-733.
11. Wang, Y., W. M. Huang, and D. E. Taylor. 1993. Cloning and nucleotide sequence of the Campylobacter jejuni gyrA gene and characterization of quinolone resistance mutations. Antimicrob. Agents Chemother. 37:457-463.
12. Xia, H. H., B. C. Yu Wong, N. J. Talley, and S. K. Lam. 2002. Alternative and rescue treatment regimens for Helicobacter pylori eradication. Expert Opin. Pharmacother. 3:1301-1311.
13. Yoshida, H., M. Bogaki, M. Nakamura, and S. Nakamura. 1990. Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrob. Agents Chemother. 34:1271-1272.
14. Zullo, A., C. Hassan, V. De Francesco, R. Lorenzetti, M. Marignani, S. Angeletti, E. Ierardi, and S. Morini. 2002. A third-line levofloxacin-based rescue therapy for Helicobacter pylori eradication. Dig. Liver Dis. 35:232-236.